Diosmetin

520-34-3

C16H12O6

DMSO : >= 35 mg/mL (116.57 mM)

Metabolic Enzyme/Protease

Diosmetin is a natural flavonoid which inhibits human CYP1A enzyme activity with an IC₅₀ of 40 uM in HepG2 cell. IC50 & Target: IC50: 40 uM (Others, HepG2 cell)^[1] In Vitro: Diosmetin inhibits cell proliferation in HepG2 cells in a concentration-dependent manner. Untreated HepG2 cells grow well and are observed to have with normal skeletons, whereas cells treated with diosmetin are distorted and a number of them become round and floating^[1]. In Vivo: Pretreatment with diosmetin significantly reduces serum levels of amylase and lipase; the histological injury; the secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6; myeloperoxidase (MPO) activity, trypsinogen activation peptide (TAP) level, the expression of inducible nitric oxide synthase (iNOS); and the nuclear factor (NF)-kappaB activation in cerulein-induced acute pancreatitis^[2].